Dose matters for stereotactic body radiotherapy for early stage non-small cell lung cancer
Ann Transl Med
.
2020 Sep;8(18):1197.
doi: 10.21037/atm-20-3149.
Authors
Christian C Okoye
1
,
C Jane Cho
2
,
Mitchell Liu
3
,
Alexander V Louie
4
,
Olusola Obayomi-Davies
5
,
Shankar Siva
6
,
Simon S Lo
2
Affiliations
1
Department of Radiation Oncology, St. Bernards Medical Center, Jonesboro, AR, USA.
2
Department of Radiation Oncology, University of Washington School of Medicine, Seattle, WA, USA.
3
BC Cancer-Vancouver Clinic, Vancouver, Canada.
4
Department of Radiation Oncology, Sunnybrook Health Science Centre, Toronto, ON, Canada.
5
Department of Radiation Oncology, WellStar Medical Group, Marietta, GA, USA.
6
Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.
PMID:
33241046
PMCID:
PMC7576082
DOI:
10.21037/atm-20-3149
No abstract available
Publication types
Editorial
Comment